Your browser doesn't support javascript.
loading
An introduction to the Marburg virus vaccine consortium, MARVAC.
Cross, Robert W; Longini, Ira M; Becker, Stephan; Bok, Karin; Boucher, David; Carroll, Miles W; Díaz, Janet V; Dowling, William E; Draghia-Akli, Ruxandra; Duworko, James T; Dye, John M; Egan, Michael A; Fast, Patricia; Finan, Amy; Finch, Courtney; Fleming, Thomas R; Fusco, Joan; Geisbert, Thomas W; Griffiths, Anthony; Günther, Stephan; Hensley, Lisa E; Honko, Anna; Hunegnaw, Ruth; Jakubik, Jocelyn; Ledgerwood, Julie; Luhn, Kerstin; Matassov, Demetrius; Meshulam, Jeffrey; Nelson, Emily V; Parks, Christopher L; Rustomjee, Roxana; Safronetz, David; Schwartz, Lauren M; Smith, Dean; Smock, Paul; Sow, Ydrissa; Spiropoulou, Christina F; Sullivan, Nancy J; Warfield, Kelly L; Wolfe, Daniel; Woolsey, Courtney; Zahn, Roland; Henao-Restrepo, Ana María; Muñoz-Fontela, César; Marzi, Andrea.
Affiliation
  • Cross RW; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Longini IM; Department of Biostatistics, University of Florida, Gainesville, Florida, United States of America.
  • Becker S; Institute for Virology, Philipps-Universität Marburg, Marburg, Germany.
  • Bok K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Boucher D; U.S. COVID-19 Response at U.S. Department of Health and Human Services, Washington, DC, United States of America.
  • Carroll MW; Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, United Kingdom.
  • Díaz JV; World Health Organization, Geneva, Switzerland.
  • Dowling WE; Coalition for Epidemic Preparedness Innovations (CEPI), Washington, Washington, DC, United States of America.
  • Draghia-Akli R; Johnson & Johnson-Global Public Health Research and Development, Spring House, Pennsylvania, United States of America.
  • Duworko JT; Partnership for Research on Infectious Diseases in Liberia, Monrovia, Liberia.
  • Dye JM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.
  • Egan MA; Auro Vaccines, Pearl River, New York, United States of America.
  • Fast P; IAVI, New York, New York, United States of America.
  • Finan A; Sabin vaccine Institute, Washington, DC, United States of America.
  • Finch C; Sabin vaccine Institute, Washington, DC, United States of America.
  • Fleming TR; University of Washington, Seattle, Washington, United States of America.
  • Fusco J; Public Health Vaccines, Cambridge, Massachusetts, United States of America.
  • Geisbert TW; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Griffiths A; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America.
  • Günther S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Hensley LE; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.
  • Honko A; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America.
  • Hunegnaw R; Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Jakubik J; Sabin vaccine Institute, Washington, DC, United States of America.
  • Ledgerwood J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Luhn K; Janssen Vaccines & Prevention, Leiden, the Netherlands.
  • Matassov D; Auro Vaccines, Pearl River, New York, United States of America.
  • Meshulam J; Auro Vaccines, Pearl River, New York, United States of America.
  • Nelson EV; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Parks CL; IAVI, New York, New York, United States of America.
  • Rustomjee R; Sabin vaccine Institute, Washington, DC, United States of America.
  • Safronetz D; Zoonotic Diseases and Special Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Schwartz LM; World Health Organization, Geneva, Switzerland.
  • Smith D; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada.
  • Smock P; Sabin vaccine Institute, Washington, DC, United States of America.
  • Sow Y; Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
  • Spiropoulou CF; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Sullivan NJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Warfield KL; Emergent BioSolutions, Gaithersburg, Maryland, United States of America.
  • Wolfe D; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada.
  • Woolsey C; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Zahn R; Janssen Vaccines & Prevention, Leiden, the Netherlands.
  • Henao-Restrepo AM; World Health Organization, Geneva, Switzerland.
  • Muñoz-Fontela C; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
PLoS Pathog ; 18(10): e1010805, 2022 10.
Article in En | MEDLINE | ID: mdl-36227853
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Vaccines / Marburgvirus / Marburg Virus Disease Limits: Animals / Humans Language: En Journal: PLoS Pathog Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Vaccines / Marburgvirus / Marburg Virus Disease Limits: Animals / Humans Language: En Journal: PLoS Pathog Year: 2022 Document type: Article Affiliation country: Country of publication: